REPUBLIC OF GHANA
Ministry of Health
Ghana National Drugs Programme
(GNDP)
GHANA ESSENTIAL
MEDICINES LIST
SIXTH EDITION, 2010
© 2010 Ministry of Health (GNDP) Ghana
All rights reserved. No part of this publication may be reproduced, stored in a retrieval
system, or transmitted in any form or by any means, electronic, mechanical,
photocopying, recording and/or otherwise, without prior written permission of the
Ministry of Health, Ghana
Essential Drugs List & National Formulary with Therapeutic Guidelines, 1st Edition,
1988
Essential Drugs List & National Formulary with Therapeutic Guidelines, 2nd Edition,
1993
Essential Drugs List & National Formulary with Therapeutic Guidelines, 3rd Edition,
1996
Essential Drugs List, 4th Edition, 2000
Essential Medicines List, 5th Edition, 2004
Essential Medicines List, 6th Edition, 2010
ISBN 978-9988-1-2539-4
For all enquiries write to the publishers:
Ghana National Drugs Programme (GNDP)
Ministry of Health
P. O. Box MB-582, Accra, Ghana, West Africa
Tel: (0)30 2661 670/1
Fax: (0)30 2664 309
E-mail: gndp@ghndp.org
Website: www.ghndp.org
Legal Disclaimer
Care has been taken to confirm the accuracy of the information presented and to
describe generally accepted practices. However, the authors, editor and publishers
are not responsible for errors and omissions or any consequences from application of
the information in this booklet and make no warranty, expressed or implied, with
respect to the content of the publication.
Printed by Yamens Press. Ltd. Accra, Ghana, West Africa.
Tel: (0)30 2223 222
Materials Development Consultant: E.T.A. Abbey
P. O. Box AN 5116, Accra, Ghana, West Africa.
Tel: (0)30 2304 211 / (0)30 2313 843
Developed by Logical Designs
Tel: (0)30 2251 626, (0)244 215 903
E-mail: logicandy@gmail.com
Acknowledgements
The review of the Standard Treatment Guidelines 2010 by the Ministry of
Health / Ghana Health service and its agencies has been successfully
completed as a result of the recommendations and contributions received
from:
MOH/GHS/School of Medicine and Pharmacy Executives
Dr. B. Kunbuor
Hon. Minister of Health
Dr. Elias K. Sory
Director General, Ghana Health
Service (GHS)
Dr. Sylvester D. Anemana
Ag. Chief Director, MOH
Mr. James Ohemeng Kyei
Chief Pharmacist, GHS/MOH
Mr. George Dakpalah
Director, Policy Planning Monitoring
and Evaluation (PPME), MOH
Mr. Samuel Boateng
Director, Ministry of Health (MOH)
Dr. Cynthia Bannerman
Institutional Care Division, GHS
Mrs. Freda Bartels Mensah
Ag. Director, Procurement and Supplies,
MOH
Mr. Sylvester Mensah
CEO, National Health Insurance Authority
Dr. Akwasi Osei
Chief Psychiatrist, GHS
Dr. (Mrs.) G. Quansah Asare
Director, Family Health, GHS
Prof. Nii Otu Nartey
CEO, Korle Bu Teaching Hospital (KBTH)
Prof. Ohene Adjei
CEO, Komfo Anokye Teaching Hospital
(KATH)
Prof. (Mrs.) C. Ntim Amponsah Dean, University of Ghana Medical School
(UGMS)
Prof. Kwabena Danso
Dean, School of Medical Sciences (SMS),
Kwame Nkrumah University of Science
and Technology (KNUST)
Prof. Mahama Duwiejua
Dean, Faculty of Pharmacy and
Pharmaceutical Sciences, KNUST
Mrs. Joycelyn Azeez
Head, Procurement Unit, MOH
Mr. Peter Ekow Gyimah
Head, Central Medical Stores, MOH
Expert Committee Members
Dr. F. Ofei (Chairman)
Dr. K. Aboah
Dr. A. Akpalu
Mr. P. Anum
Dr. K. Aryee
Dr. J.N. Clegg-Lamptey
Dr. A.N.O. Dodoo
Dr. (Mrs.) I. Ekem
Department of Medicine and
Therapeutics, UGMS
Department of Surgery, SMS, KNUST
Department of Medicine, KBTH
National Drugs Information Centre,
Pharmacy Council
Department of Obstetrics and
Gynaecology, UGMS
Department of Surgery, UGMS
Centre for Tropical Clinical Pharmacology
and Therapeutics, UGMS
Department of Haematology, UGMS
Acknowledgements
Dr. (Mrs.) A. Forson
Prof. E. H. Frimpong
Dr. E. D. Kitcher
Prof. G. Klufio
Prof. M. O. Mate-Kole
Mr. A. Mensah
Prof. S. Naaeder
Mrs. Amah Nkansah
Prof. H. Addo
Dr. (Mrs.) E. Ofori-Adjei
Dr. S. Ohene
Dr. I. Owusu
Prof. (Mrs.) B. Quarm Goka
Mr. R. Tetteh
Prof. (Mrs.) J. Welbeck
Editorial Committee Members
Dr. F. Ofei (Chairman)
Department of Medicine and
Therapeutics, UGMS
Department of Medical Microbiology,
SMS, KNUST
Department of Surgery, UGMS
Department of Surgery, UGMS
Department of Medicine and
Therapeutics, UGMS
Department of Pharmacy, KATH
Department of Surgery, UGMS
Department of Pharmacy, KBTH
Department of Medicine and
Therapeutics, UGMS
University Health Services, University of
Ghana
Department of Psychiatry, UGMS
Department of Medicine, SMS, KNUST
Department of Child Health, UGMS
Department of Pharmacy, KBTH
Department of Child Health, UGMS
Mrs. Martha Gyansa-Lutterodt
Mrs. Amah Nkansah
Prof. (Mrs.) J. Welbeck
Department of Medicine and
Therapeutics, UGMS
Department of Medicine, KBTH
Centre for Tropical Clinical Pharmacology
and Therapeutics, UGMS
Ghana National Drugs Programme, MOH
Department of Pharmacy, KBTH
Department of Child Health, UGMS
Coordinators
Mrs. Augustina Koduah
Mr. Brian Adu Asare
Ghana National Drugs Programme, MOH
Ghana National Drugs Programme, MOH
Dr. A. Akpalu
Dr. A.N.O. Dodoo
Programme Managers
Dr. P. Aboagye
Dr. N.A. Addo
Dr. K.O. Antwi-Agyei
Dr. (Mrs.) C. Bart-Plange
Dr. F. Bonsu
Reproductive Health Unit, GHS
National AIDS/STI Control Programme
(NACP)
Expanded Programme on Immunization
(EPI), GHS
National Malaria Control Programme
(NMCP), GHS
National Tuberculosis Programme.
(NTP), GHS
Acknowledgements
Dr. O. Debrah
Dr. Agana Nsiire
Dr. S. Kyei Faried
Dr. (Mrs.) I. Sagoe-Moses
Dr. Yaa Osei
Eyecare Programme, GHS
National Yaws Eradication Programme
(NYEP)
Head, Disease Control Unit, GHS
Child Health, GHS
Family Planning, GHS
World Health Organisation (WHO)
Dr. Daniel Kertesz
Country Representative, Ghana
Mrs. Edith Andrews-Annan
National Professional Officer, Essential
Drugs and Medicines Policy, Ghana
Management Sciences for Health
Mr. Kwesi Eghan
Country Representative, MSH/SPS/USAID
Ghana National Drugs Programme
Mrs. Martha Gyansa-Lutterodt Programme Manager
Mrs. Augustina Koduah
Assistant Programme Manager
Mr. Brian Adu Asare
Programme Officer
Mrs. Stella A. Ntow
Principal Programme Accountant
Mr. Joshua Y. Quarshie
Accountant
Agnes Osei Konadu
Account Officer
Mrs. Mispah Afram
Office Manager
Diana Edusei
Front Desk Manager
The Royal Netherlands Government
for their support to the Ghana National Drugs Programme (GNDP)
GNDP Steering Committee
Mr. Robert Joseph Mettle-Nunoo
Dr. Sylvester D. Anemana
Dr. Elias K. Sory
Mr. James Ohemeng Kyei
Mr. T.C.P. Corquaye
Mr. David Anim Addo
Mrs. Freda Bartels Mensah
Mr. F. Dakpallah
Prof. David Ofori-Adjei
Mr. Herman Dusu
Dr. (Mrs.) I. Agyepong
Prof. Mahama Duwiejua
Mrs. Martha Gyansa-Lutterodt
Hon. Deputy Minister, Ministry of Health
Ag. Chief Director, MOH
Director General, GHS
Chief Pharmacist,GHS/MOH
Ag. Chairman, Food & Drugs Board
Chairman, Pharmacy Council
Ag. Director, Procurement and Supplies,
MOH
Director, PPME, Ministry of Health
University of Ghana Medical School
Financial Controller, MOH
Regional Director of Health Services,
Greater Accra Region
Dean, Faculty of Pharmacy and
Pharmaceutical Sciences, KNUST
Programme Manager, GNDP/MOH
Preface
Essential Medicines are those that satisfy the priority health care needs of the
population. They are selected with due regard to public health relevance, evidence
on efficacy, safety and comparative cost-effectiveness.
This edition of the Essential Medicines List (EML) 2010 for Ghana has been derived
from its companion Standard Treatment Guidelines 2010 to ensure harmony in
treatment, procurement and re-imbursements. The medicines listed have been
coded according to the Health Commodity Codes Catalogue of the Ministry of
Health (2008) and their levels of use, based on the type of health facility, including
midwifery practice, have been indicated.
I hope that all health providers would embrace this document as it continues to be
an important tool in the management of medicines in the country. Meanwhile in line
with its policy, the Ministry will leave no stone unturned to increase access to
essential medicines that satisfy the priority health care needs of all Ghanaians.
Dr. Benjamin Kunbuor
Hon. Minister for Health
May 2010
Introduction
The medicines listed in this document are derived from the revised Standard
Treatment Guidelines (2010) of the Ministry of Health. The criteria used to guide
the selection of medicines were dependent on those used for the selection of
medicines for the World Health Organisation Model List of Essential Medicines
The revision of the Standard Treatment Guidelines was based on published
evidence or expert opinion. The final document was then field-tested among all
categories of health professionals. As a consequence, medicines mentioned for the
treatment of health problems in the Standard Treatment Guidelines have been
included in this edition of the Essential Medicines List. In addition, comments on
the 2004 Essential Medicines List collected from health professionals were
considered on the basis of the WHO criteria by an expert panel. The criteria are:
•
drug selection should be based on the results of efficacy and safety
evaluations obtained in controlled clinical trials and epidemiological studies,
and on the performance in general use in a variety of medical settings;
•
when several drugs are available for the same indication, only the drug
and the pharmaceutical form that provides the more convenient benefit / risk
ratio should be selected;
•
when two or more drugs are therapeutically equivalent, the selection
should fall on:
- the drug that has been more thoroughly investigated,
- the drug with the most favourable pharmacokinetic properties,
- the drug with the lowest cost, calculated on the basis of the whole course
of treatment,
- the drug with which health workers are already familiar,
- the drug for which economically convenient manufacturing is available in
the country,
- the drug which shows better stability at the available storage conditions;
A fixed dose combination should be accepted only if clinical documentation
justifies the concomitant use of more than one drug, and the combination provides
a proven advantage over single compounds administered separately in therapeutic
effect, safety, patients' compliance or cost.
Furthermore, guidelines are proposed to confine the circulation of essential drugs
to specific and appropriate settings and levels of health care delivery. For this, drugs
have been grouped into the following categories:
Level A
Level M
Level B1
Level B2
Level C
Level D
Level SD
Level PD
- Community
- Midwifery
- Health Centre without Doctor
- Health Centre with Doctor
- District Hospital
- Regional/Teaching Hospital
- Specialist Drugs
- Programme Drugs
Also drugs marked as NR imply that at the time of publication, those drugs were not
reimbursed by the National Health Insurance Authority (NHIA); whereas drugs
marked as R are drugs that are reimbursed by the NHIA based on the benefits
package.
Specialist Drugs are restricted for use by qualified specialists who may request for
them. Programme Drugs are those drugs used in public health programmes of the
Ministry of Health and as such used within the guidelines of the specific
programmes.
In previous editions, the British Appoved Name (BAN) was adopted for all medicines
in the Essential Medicines List (EML). This current issue uses only the Recommended
International Non-Proprietary Name (rINN) in line with WHO recommendations and
practice.
It is the hope of the Ministry that health professionals will support this document by
providing comments and suggestions towards to inform the next review
Comments and suggestions should be sent to:
The Programme Manager
Ghana National Drugs Programme
Ministry of Health
P.O. Box MB-582, Accra, Ghana
Tel:
+233 (0) 302 661 670/1
Fax:
+233 (0) 302 664309
E-mail: gndp@ghndp.org
Website: www.ghndp.org
Essential Medicines List
LEVEL OF
NHIA
CARE
STATUS
Adrenaline (Epinephrine) Injection,
100 microgram/ml (1:10 000)
B1/M
R
ADRENAIN1
Adrenaline (Epinephrine) Injection,
1 mg/ ml (1:1000)
B1/M
R
ADRENAIN2
Atropine Injection, 0.6 mg/ml
Atropine Injection, 1 mg/ml
B2
C
R
ATROPIIN1
R
ATROPIIN2
Bupivacaine + Adrenaline
Injection, (0.25% + 1:200 000)
C
NR
BUPADRIN1
C
NR
BUPADRIN2
C
R
BUPIVAIN2
C
R
BUPIVAIN1
B1/M
R
DIAZEPIN1
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
1.
1.1
CODE
ANAESTHETICS
GENERAL ANAESTHETICS
Bupivacaine + Adrenaline
Injection, (0.5% + 1:200 000)
Bupivacaine Injection, 0.25% (Plain)
Bupivacaine Injection, 0.5% (Heavy)
Diazep am Injection, 5 mg/ml
Ephedrine Hydrochloride Injection,
C
50 mg
Fentanyl Citrate Injection, 50 microgram C
R
EPHEDRIN1
NR
FENCITIN1
Halothane Inhalation, 250 ml
C
NR
HALOTHGA1
Isoflurane Inhalation, 100 ml
C
NR
ISOFLUGA1
Ketamine Injection, 10 mg/ml
C
R
KETAMIIN1
Ketamine Injection, 50 mg/ml
Ketorolac Injection, 30 mg/ml
C
C
R
NR
KETAMIIN2
KETOROIN1
Lidocaine Injection, 2%
B1/M
R
LIDOCAIN2
Midazolam Injection, 5 mg/ml
Midazolam Tablet, 15 mg
Neostigmine Injection, 0.5 mg/ml
C
C
C
R
R
NR
MIDAZOIN1
MIDAZOTA1
NEOSTIIN2
Neostigmine Injection, 2.5 mg/ml
C
R
NEOSTIIN1
Nitrous Oxide Inhalation
C
NR
NITOXIGA1
D
NR
NORADRIN1
B1/M
NR
OXYGENGA1
C
NR
PANBROIN1
Noradrenaline (Norepinephrine)
Injection, 1 mg/ml (1:1000)
Oxygen (Medicinal Gas) Inhalation
Pancuronium Bromide, 2 mg/ml
Ghana Essential Medicines List
LEVEL OF
NHIA
CARE
STATUS
C
R
PROPOFIN1
C
NR
SUXAMEIN1
Thiopentone Sodium Injection, 1 g
C
NR
THISODIN1
Vecuronium Bromide Injection, 10 mg
C
NR
VECBROIN1
C
R
BUPIVAIN2
B2
R
LIDADRIN2
THERAPEUTIC NAME OF DRUG, DOSAGE
CLASS
1.1
1.2
FORM AND STRENGTH
GENERAL ANAESTHETICS (Continued)
Propofol Injection, 10 mg/ml
Suxamethonium Succinylcholine
Injection, 50mg/ml
CODE
LOCAL ANAESTHETICS
Bupivacaine Injection, 5 mg/ml
Lidocaine + Adrenaline Injection,
(10 mg/ml + 5 microgram/ml)
Lidocaine + Adrenaline Injection,
(20 mg/ml + 5 microgram/ml)
Lidocaine Cream, 2 %
B2
R
LIDADRIN3
A/M
R
LIDOCACR1
Lidocaine Gel, 2 %
Lidocaine Injection, 1 %
B1/M
B1/M
R
R
LIDOCAGE2
LIDOCAIN1
Lidocaine Injection, 2 %
Lidocaine Injection, 20 mg/ml
B1/M
B2
R
R
LIDOCAIN2
LIDOCAIN3
Lidocaine Spray, 10 %
R
LIDOCASP1
B1/M
2. PRE-OPERATIVE MEDICATIONS AND SEDATION FOR SHORT-TERM PROCEDURES
Atropine Injection, 0.6 mg/ml
B2
R
ATROPIIN1
Diazepam Injection, 5 mg/ml
B1/M
R
DIAZEPIN1
Lorazepam Injection, 4 mg/ml
Lorazepam Tablet, 1 mg
Lorazepam Tablet, 2 mg
Midazolam Injection, 1mg/ml
R
R
R
R
LORAZEIN1
LORAZETA1
LORAZETA2
MIDAZOIN1
Midazolam Tablet, 15 mg
C
R
3. ANALGESICS, ANTIPYRETICS, NSAIDS AND DRUGS USED IN GOUT
MIDAZOTA1
3.1 NON-OPIOID NON-STEROIDAL ANALGESICS
Acetyl Salicylic Acid Tablet, 300 mg
Diclofenac Capsule, 75 mg
Diclofenac Gel, 1%
Diclofenac Injection, 25 mg/ml
Diclofenac Suppository, 100 mg
Diclofenac Suppository, 50 mg
D
B2
B2
C
B1/M
B2
A/M
B2
A/M
A/M
R
R
R
R
R
R
ACETYLTA1
DICLOFCA1
DICLOFGE1
DICLOFIN1
DICLOFRE2
DICLOFRE1
Ghana Essential Medicines List
LEVEL OF
NHIA
CARE
STATUS
B2
B2
R
R
DICLOFTA1
DICLOFTA2
Ibuprofen Suspension, 100 mg/ 5 ml
Ibuprofen Tablet, 200 mg
B1/M
B1/M
R
R
IBUPROSU1
IBUPROTA1
Ibuprofen Tablet, 400 mg
Paracetamol Suppository, 125 mg
Paracetamol Suppository, 250 mg
Paracetamol Suppository, 300 mg
B1/M
A/M
A/M
A/M
R
R
R
R
IBUPROTA2
PARACERE1
PARACERE2
PARACERE3
Paracetamol Suppository, 500 mg
Paracetamol Syrup, 120 mg/ 5 ml
Paracetamol Tablet, 500 mg
A/M
A/M
A/M
R
R
R
PARACERE4
PARACESY1
PARACETA1
SD
R
MORPHIIN2
C
R
MORPHIIN1
C
R
MORSULTA2
C
R
B2
R
MORSULTA1
PETHIDIN1
B2
NR
TRAHYDIN1
B2
NR
TRAHYDCA1
B2
B2
R
R
ALLOPUTA1
ALLOPUTA2
Adrenaline Injection, 1 mg/ml (1:1000)
Chlorphenamine Syrup, 2 mg/ 5 ml
B1/M
A/M
R
R
ADRENAIN1
CHLPHESY1
Chlorphenamine Tablet, 4 mg
Dexamethasone Injection, 4 mg/ml
A/M
C
R
R
CHLPHETA1
DEXAMEIN1
D
R
DEXAMETA1
B1
B1/M
R
R
HYDROCCR1
HYSOSUIN1
THERAPEUTIC NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
Diclofenac Tablet, 25 mg
Diclofenac Tablet, 50 mg
3.2
3.3
OPIOID ANALGESICS
Morphine Injection, 10 mg/ml
(Preservative - Free)
Morphine Injection, 10 mg/ml
Morphine Sulphate Tablet, 30 mg
(Slow -Release)
Morphine Sulphate Tablets, 10 mg
Pethidine Injection, 50 mg/ml
Tramadol Hydrochloride Injection,
50 mg/ml
Tramadol Hydrochloride Capsule, 50 mg
DRUGS USED IN GOUT
Allopurinol Tablet, 100 mg
Allopurinol Tablet, 300 mg
CODE
4. ANTI-ALLERGIC DRUGS
Dexamethasone Tablet, 500 micrograms
Hydrocortisone Cream, 1 %
Hydrocortisone Sodium Succinate
Injection, 100 mg
Ghana Essential Medicines List
THERAPEUTIC NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
Hydrocortisone Tablet, 10 mg
Hydrocortisone Tablet, 20 mg
Prednisolone Tablet, 5 mg
Promethazine Hydrochloride Elixir,
5 mg/5 ml
Promethazine Hydrochloride Injection,
25 mg /ml
Promethazine Hydrochloride Tablet,
25 mg
LEVEL OF
NHIA
CARE
C
SD
B2
B1/M
STATUS
NR
NR
R
R
HYDROCTA1
HYDROCTA2
PREDNITA1
PROHYDEL1
B1/M
R
PROHYDIN1
B1/M
R
PROMETTA1
R
R
R
R
R
R
R
R
R
NR
ACETYLIN1
ACTCHAPO1
ATROPIIN1
BENZATIN1
DIAZEPIN1
FLUMAZIN1
NALOXOIN1
NALOXOIN2
PHYTOMIN1
PHYTOMTA1
SD
R
CARBAMTA3
5. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
5.1 SPECIFIC ANTIDOTES
Acetylcysteine Injection, 200 mg/ml
C
Activated Charcoal Powder, 50 g
A/M
Atropine Injection, 0.6 mg/ml
B2
Benzatropine Injection, 1 mg/ml
C
Diazepam Injection, 10 mg/ml
B1/M
Flumazenil Injection, 0.2 mg
D
Naloxone Injection, 200 microgram /ml
C
Naloxone Injection, 400 microgram /ml
C
Phytomenadione Injection, 10 mg/ml
B2/M
Phytomenadione Tablet, 10 mg
B2
6. ANTICONVULSANTS
Carbamazepine Tablet, 200 mg
(Sustained -Release)
CODE
Carbamazepine Tablet, 400 mg
(Sustained -Release)
Carbamazepine Tablet, 100 mg
Carbamazepine Tablet, 200 mg
Diazepam Injection, 5 mg/ml
SD
R
CARBAMTA4
C
C
B1/M
R
R
R
CARBAMTA1
CARBAMTA2
DIAZEPIN1
Diazepam Rectal Tubes, 2 mg/ml
Ethosuximide Syrup, 250 mg/ 5 ml
Ethosuximide Tablet, 250 mg
Magnesium Sulphate Injection, 20 %
Magnesium Sulphate Injection, 25 %
Magnesium Sulphate Injection, 50 %
A/M
D
D
B1/M
B2/M
C
R
R
R
R
R
R
DIAZEPRS1
ETHOSUSY1
ETHOSUTA1
MAGSULIN1
MAGSULIN2
MAGSULIN3
Phenobarbital Injection, 200 mg/ml
B1
R
PHENOBIN1
Ghana Essential Medicines List
THERAPEUTIC
CLASS
NAME OF DRUG, DOSAGE
FORM AND STRENGTH
LEVEL OF
NHIA
CARE
STATUS
CODE
Phenytoin Injection, 50 mg/ml
Phenytoin Sodium Capsule, 100 mg
D
B2
R
R
PHENYTIN1
PHENYTCA2
Phenytoin Sodium Tablet, 100 mg
Primidone Tablet, 250 mg
B2
C
R
R
PHENYTTA1
PRIMIDTA1
Sodium Valproate Syrup, 200 mg/ 5 ml
Sodium Valproate Capsule, 500 mg
(Slow-Release)
Sodium Valproate Capsule, 200 mg
Sodium Valproate Tablet, 200 mg
D
D
R
R
SODVALSY1
SODVALCA2
D
D
R
R
SODVALCA1
SODVALTA1
Albendazole Syrup, 100 mg/ 5ml
Albendazole Tablet, 200 mg
Albendazole Tablet, 400 mg
A/M
A/M
A/M
R
R
R
ALBENDSY1
ALBENDTA1
ALBENDTA2
Mebendazole Tablet, 100 mg
Mebendazole Tablet, 500 mg
A/M
A/M
R
R
MEBENDTA1
MEBENDTA2
B2
B2
B2
R
R
R
NICLOSTA1
TIABENSU1
TIABENTA1
B1
R
PRAZIQTA1
B2
R
COAMOXIN1
B2
R
COAMOXSU1
B2
R
COAMOXSU2
B2
R
COAMOXTA2
B2
R
COAMOXTA1
7. ANTI-INFECTIVE DRUGS
7.1
7.1.1
ANTIHELMINTHIC DRUGS
Intestinal Antihelminthic Drugs
Niclosamide Tablet, 500 mg
Tiabendazole Suspension, 50 mg/ml
Tiabendazole Tablet, 500 mg
7.1.2 Antischistosomal Drugs
Praziquantel Tablet, 600 mg
7.2 ANTIBACTERIAL DRUGS
7.2.1 Penicillins
Amoxicillin + Clavulanic Acid
Injection, (500 mg + 100 mg)
Amoxicillin + Clavulanic Acid
Suspension, (250 mg + 62 mg)
Amoxicillin + Clavulanic Acid
Suspension, (400 mg + 57mg)
Amoxicillin + Clavulanic Acid
Tablet, (250 mg + 125 mg)
Amoxicillin + Clavulanic Acid
Tablet, (500 mg + 125 mg)
Ghana Essential Medicines List
THERAPEUTIC NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
Amoxicillin Capsule, 250 mg
Amoxicillin Capsule, 500 mg
Amoxicillin Suspension, 125 mg/ 5 ml
Ampicillin Injection, 500 mg
Benzathine Benzylpenicillin Injection,
1.2 MU
Benzathine Benzylpenicillin Injection,
2.4 MU
Benzyl Penicillin Injection, 1 MU
Benzyl Penicillin Injection, 5 MU
Cloxacillin Injection, 250 mg
Cloxacillin Injection, 500 mg
Flucloxacillin Capsule, 250 mg
Flucloxacillin Suspension, 125 mg/ 5 ml
Phenoxymethyl Penicillin Tablet,
250 mg
Tetracycline Capsule, 250 mg
7.2.2
Other Antibacterial Drugs
Azithromycin Capsule, 250 mg
Azithromycin Oral suspension,
200 mg/ml
Cefaclor Capsule, 250 mg
Cefaclor Capsule, 500 mg
Cefaclor Suspension, 125 mg/ 5ml
Cefaclor Suspension, 250 mg/ 5ml
Cefotaxime Injection, 1 g
Cefotaxime Injection, 500 mg
Ceftriaxone Injection, 1 g
Ceftriaxone Injection, 2 g
Ceftriaxone Injection, 250 mg
Cefuroxime Injection, 1.5 g
Cefuroxime Injection, 750 mg
Cefuroxime Suspension, 125 mg/ 5 ml
Cefuroxime Tablet, 125 mg
Cefuroxime Tablet, 250 mg
Chloramphenicol Injection, 1 g
Ciprofloxacin Infusion, 2 mg/ml
LEVEL OF
NHIA
CARE
STATUS
CODE
B1/M
B1/M
B1 /M
B1/M
R
R
R
R
AMOXICCA1
AMOXICCA2
AMOXICSU1
AMPICIIN1
PD
NR
BENBENIN1
PD
NR
BENBENIN2
B2
B2
R
R
BENZYLIN1
BENZYLIN2
B2
B2
R
R
CLOXACIN1
CLOXACIN2
B1/M
B1/M
R
R
FLUCLOCA1
FLUCLOSU1
B1/M
R
PHEPENTA1
B2
R
TETRACCA1
C
R
AZITHRCA1
C
R
AZITHRSU1
B2
B2
B2
B2
C
C
C
C
PD
C
C
C
C
C
C
B2
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
CEFACLCA1
CEFACLCA2
CEFACLSU1
CEFACLSU2
CEFOTAIN2
CEFOTAIN1
CEFTRIIN2
CEFTRIIN3
CEFTRIIN1
CEFUROIN2
CEFUROIN1
CEFUROSU1
CEFUROTA1
CEFUROTA2
CHLORAIN1
CIPROFIN1
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
7.2.3
Ciprofloxacin Tablet, 250 mg
Ciprofloxacin Tablet, 500 mg
Clarithromycin Capsule, 250 mg
Clarithromycin Capsule, 500 mg
Clarithromycin Paediatric Suspension,
125 mg/m l
Clindamycin Capsule, 150 mg
Clindamycin Injection, 150 mg/ml
Clindamycin Suspension, 75 mg/ 5 ml
Co-trimoxazole Suspension,
(200 mg + 40 mg) / 5 ml
Co-trimoxazole Tablet, (400 mg + 80 mg)
Doxycycline Capsule, 100 mg
Erythromycin Syrup, 125 mg/ 5 ml
Erythromycin Tablet, 250 mg
Gentamicin Injection, 40 mg/ml
Neomycin Tablet, 500 mg
Nitrofurantoin Tablet, 100 mg
Antituberculous Drugs
Ethambutol Tablet, 100 mg
Ethambutol Tablet, 400 mg
Isoniazid Tablet, 100 mg
Isoniazid Tablet, 300 mg
Pyrazinamide Tablet, 150 mg
Pyrazinamide Tablet, 400 mg
Pyridoxine Tablet, 100 mg
Pyridoxine Tablet, 50 mg
Rifa mpicin + Isoniazid + Ethambutol
Tablet, (150 mg + 75 mg + 275 mg)
Rifampicin + Isoniazid + Pyrazinamide +
Ethambutol Tablet,
(150 mg + 75 mg + 400 mg + 275 mg)
Rifampicin + Isoniazid + Pyrazinamide
Tablet, (60 mg + 30 mg + 150 mg)
Rifampicin + Isoniazid Tablet,
(150 mg + 75 mg)
Rifampicin + Isoniazid Tablet,
(60 mg + 30 mg)
LEVEL OF
NHIA
CARE
STATUS
B1/M
B1/M
C
C
R
R
R
R
CIPROFTA1
CIPROFTA2
CLARITCA1
CLARITCA2
C
R
CLARITSU1
D
D
D
R
R
R
CLINDACA1
CLINDAIN1
CLINDASU1
B1
R
COTRIMSU1
B1
PD/SD
B1/M
B1/M
C
C
B2
R
R
R
R
R
R
R
COTRIMTA2
DOXYCYCA1
ERYTHRSY1
ERYTHRTA1
GENTAMIN1
NEOMYCTA1
NITROFTA1
PD
PD
PD
PD
PD
PD
B2
B2
NR
NR
NR
NR
NR
NR
R
R
ETHAMBTA1
ETHAMBTA2
ISONIATA1
ISONIATA2
PYRAZITA1
PYRAZITA2
PYRIDOTA3
PYRIDOTA2
PD
NR
RIISETTA1
PD
NR
RIISPYTA2
PD
NR
RIISPYTA1
PD
NR
RIFISOTA2
PD
NR
RIFISOTA1
CODE
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
Rifampicin Tablet, 300 mg
Streptomycin Sulphate Injection, 1 g
7.3 ANTIFUNGAL DRUGS FOR SYSTEMIC USE
Fluconaz ole Tablets, 50 mg
Griseofulvin Tablet, 125 mg
Griseofulvin Tablet, 500 mg
Itraconazole Tablet, 100 mg
Ketoconazole Tablet, 200 mg
Miconazole Oral Gel, 20 mg/g
LEVEL OF
NHIA
CARE
STATUS
PD
PD
NR
NR
RIFAMPTA2
STREPTIN1
C
B2
B2
D
C
C
R
R
R
R
R
R
FLUCONTA1
GRISEOTA1
GRISEOTA2
ITRACOTA1
KETOCOTA1
MICONAOG1
R
R
R
R
NYSTATSU1
NYSTATTA1
NYSTATTA2
TERBINTA1
R
R
METRONIN1
METRONRE1
R
METRONSU1
R
METRONSU2
Nystatin Suspension, 100 000 IU/ml
B2
Nystatin Tablet, 100 000 IU
C
Nystatin Tablet, 500 000 IU
C
Terbinafine Hydrochloride Tablet, 250 mg
D
7.4 ANTIPROTOZOAL DRUGS
7.4.1 Anti-Amoebic Drugs
Metronidazole Injection, 5 mg/ml
B2
Metronidazole Suppository, 500 mg
B2
Metronidazole Suspension, 100 mg/ 5ml
B1/M
(as benzoate)
Metronidazole Suspension, 200 mg/ 5ml
B1/M
(as benzoate)
Metronidazole Tablet, 200 mg
B1/M
7.4.2
Metronidazole Tablet, 400 mg
Tinidazole Capsule, 500 mg
Antimalarial Drugs
Artemether + Lumefantrine Dispersible
Tablet, (20 mg + 120 mg) (Co-Formulated)
Artemether + Lumefantrine Tablet,
(20 mg + 120 mg ) (Co-Formulated)
Artesunate + Amodiaquine Granular
Powder, (25 mg + 75 mg)
Artesunate + Amodiaquine Tablet,
(25 mg + 75 mg) (Co-Blistered)
Artesunate + Amodiaquine Tablet,
(50 mg + 150 mg) (Co-Blistered)
Artesunate + Amodiaquine Tablet ,
(100 mg + 270 mg) (Fixed Dose)
CODE
R
METRONTA1
B1/M
B2
R
R
METRONTA2
TINIDACA1
A/M
R
ARTLUMDT1
A/M
R
ARTLUMTA1
A/M
R
ARTAMOPO1
A/M
R
ARTAMOTA2
A/M
R
ARTAMOTA1
A/M
R
ARTAMOTA5
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
LEVEL OF
NHIA
CARE
STATUS
CODE
Artesunate + Amodiaquine Tablet,
(25 mg + 67.5 mg) (Fixed Dose)
A/M
R
ARTAMOTA3
Artesunate + Amodiaquine Tablet,
(50 mg + 135 mg) (Fixed Dose)
A/M
R
ARTAMOTA4
Artesunate Injection, 60 mg
(as Anhydrous Artesunic acid) + 5 %
Sodium bicarbonate solution for
reconstitution
B2
R
ARTESUIN1
A/M
A/M
R
R
ARTESURE2
ARTESURE1
Arthemether Injection, 40 mg/ml
B2
Arthemether Injection, 80 mg/ml
B2
Dihydroartemisinin + Piperaquine Tablet,
A/M
(40 mg + 320 mg) (Co-Formulated)
Quinine Dihydrochloride Injection,
B2
300 mg/ml in 2 mls
Quinine Dihydrochloride Syrup,
B2
20 mg/ml
R
R
ARTHEMIN1
ARTHEMIN2
R
DIHPIPTA1
R
QUINININ1
R
QUININSY1
Quinine Sulphate Tablet, 300 mg
B2/M
R
QUININTA1
PD
NR
SULPYRTA1
Artesunate Suppository, 200 mg
Artesunate Suppository, 50 mg
Sulfadoxine + Pyrimethamine Tablet,
(500 mg + 25 mg)
7.5 ANTIVIRAL DRUGS
Acyclovir Tablet, 200 mg
B2
R
ACICLOTA1
Acyclovir Injection, 25 mg/ml
C
R
ACICLOIN1
Acyclovir Suspension, 200 mg/ 5ml
B2
R
ACICLOSU2
Acetyl Salicylic Acid Tablet, 300 mg
B1
R
ACETYLTA1
Ergotamine Tartrate Tablet, 1 mg
C
R
ERGTARTA1
Ergotamine Tartrate Tablet, 2 mg
C
R
ERGTARTA2
A/M
R
PARACETA1
B2
R
PROPRATA2
8. ANTIMIGRAINE DRUGS
Paracetamol Tablet, 500 mg
Propranolol Tablet, 40 mg
Ghana Essential Medicines List
LEVEL OF
NHIA
CARE
STATUS
5-Fluorouracil Injection, 50 mg/ml
6-Mercaptopurine Tablet, 50 mg
D
D
R
NR
5FLUORIN1
MERCAPTA1
Adriamycin Hydrochloride Injection,
10 mg
D
NR
ADRIAMIN1
Adriamycin Hydrochloride Injection,
50 mg
D
R
ADRIAMIN2
Bicalutamide Tablet, 150 mg
D
NR
BICALUTA2
Bicalutamide Tablet, 50 mg
D
NR
BICALUTA1
Bleomycin Injection, 15 IU
Busulphan Tablet, 2 mg
D
D
NR
NR
BLEOMYIN1
BUSULFTA2
Busulphan Tablet, 500 microgram
Capecitabine Tablet, 500 mg
D
D
NR
R
BUSULFTA1
CAPECITA1
Chlorambucil Tablet, 2 mg
D
NR
CHLORATA1
Chlorambucil Tablet, 5 mg
D
NR
CHLORATA2
Cisplatin Injection, 50 mg
Crisantaspase Injection, 10 000 units
D
D
NR
NR
CISPLAIN1
CRISANIN1
Cyclophosphamide Injection, 200 mg
Cyclophosphamide Injection, 500 mg
D
D
NR
R
CYCLOPIN2
CYCLOPIN1
Cyclophosphamide Tablet, 50 mg
Cytarabine Injection, 100 mg
D
D
NR
NR
CYCLOPTA1
CYTARAIN1
Dacarbazine Injection, 100 mg
Daunorubicin Injection, 50 mg
D
D
NR
NR
DACARBIN1
DAUNORIN2
Docetaxel Injection (Concentrate),
20 mg/ 0.5 ml
D
R
DOCETAIN1
Estramustine Phosphate Capsules,
140 mg
D
NR
ESTPHOCA1
Estramustine Phosphate Capsules,
280 mg
D
NR
ESTPHOCA2
Etoposide Capsule, 100 mg
D
NR
ETOPOSCA1
Etoposide Injection, 20 mg/ml
D
NR
ETOPOSIN1
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
CODE
9. ANTINEOPLASTIC AND IMMUNOSUPPRESIVE DRUGS
9.1 CYTOTOXIC DRUGS
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
Flutamide Tablet, 250 mg
Folinic Acid Injection, 15 mg
Folinic Acid Tablet, 15 mg
Goserelin Injection, 10.8 mg
Goserelin Injection, 3.6 mg
Hydroxycarbamide Capsule, 500 mg
Imatinib Tablet, 100 mg
Imatinib Tablet, 400 mg
Leuprolide Acetate Injection,
3.75 mg/ml
Methotrexate Injection, 2.5 mg/ml
Methotrexate Injection, 25 mg/ml
Methotrexate Tablet, 10 mg
Methotrexate Tablet, 2.5 mg
Mitoxantrone Injection, 2 mg/ml
OncoTICE (Bacillus Calmette-BCG,
Strain TICE) Injection
Procarbazine Tablet, 50 mg
Stilboestrol Tablet, 1 mg
Stilboestrol Tablet, 2 mg
Stilboestrol Tablet, 5 mg
Thiotepa Injection, 15 mg
Vinblastine Injection, 1 mg/ml
Vincristine Injection, 1 mg
Vincristine Injection, 2 mg
Vincristine Injection, 5 mg
9.2
10.
LEVEL OF
NHIA
CARE
STATUS
CODE
D
D
D
D
D
B2
D
D
NR
NR
NR
NR
NR
NR
NR
NR
FLUTAMTA1
FOLINIIN1
FOLINITA1
GOSEREIN2
GOSEREIN1
HYDCARTA2
IMATINTA1
IMATINTA2
D
NR
LEUPROIN1
D
D
D
D
D
R
R
R
R
NR
METHOTIN1
METHOTIN2
METHOTTA2
METHOTTA1
MITOXAIN1
SD
NR
ONCOTIIN1
D
D
D
D
SD
D
D
D
D
NR
NR
NR
NR
NR
NR
NR
NR
NR
PROCARTA1
STILBOTA1
STILBOTA2
STILBOTA3
THIOTEIN1
VINBLAIN1
VINCRIIN1
VINCRIIN2
VINCRIIN3
HORMONES AND ANTIHORMONES
Prednisolone Tablet, 5 mg
B2
R
PREDNITA1
ANTIPARKINSONISM DRUGS
Benzatropine Tablet, 2 mg
Biperiden Injection, 5 mg/ml
Biperiden Tablet, 2 mg
Trihexyphenidyl Tablet, 2 mg
Trihexyphenidyl Tablet, 5 mg
C
C
C
C
C
R
NR
NR
R
R
BENZATTA1
BIPERIIN1
BIPERITA1
TRIHEXTA1
TRIHEXTA2
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
11. DRUGS AFFECTING THE BLOOD
11.1 ANTIANAEMIA DRUGS
Ferrous Sulphate + Folic Acid Tablet,
(60 mg + 250 microgram)
Ferrous Fumarate Tablet,
(100 mg Elemental Iron)
Ferrous Sulphate (BPC) Syrup,
60 mg/ 5 ml
Ferrous Sulphate Tablet,
(60 mg Elemental Iron)
Folic Acid Tablet, 5 mg
Hydroxycobalamine Injection, 1 mg/ml
11.2
Iron Dextran Injection, 100 mg/ 2 ml
Iron Sucrose Injection, 20 mg/ml
ANTICOAGULANTS AND ANTAGONISTS
Acetyl Salicylic Acid Tablet, 75 mg
(Dispersible)
Heparin [Low molecular weight]
Injection, 4000 units/ml
Heparin Injection, 1000 units/ml
Heparin Injection, 5000 units/ 0.2 ml
Heparin Injection, 5000 units/ml
Phytomenadione Tablet, 10 mg
Phytomenadione Injection, 1 mg/ml
Phytomenadione Injection, 10 mg/ml
Protamine sulphate Injection, 10 mg/ml
Streptokinase Injection, 100 000 units
Streptokinase Injection, 250 000 units
Streptokinase Injection, 750 000 units
Tirofiban Infusion, 250 micrograms/ml
(Concentrate)
Tirofiban Infusion, 50 micrograms/ml
Tranexamic Acid Capsule, 250 mg
Tranexamic Acid Injection, 100 mg/ml
Tranexamic Acid Tablet, 500 mg
Warfarin Tablet, 5 mg (Scored)
Warfarin Tablet, 1 mg
Warfarin Tablet, 3 mg
LEVEL OF
NHIA
CARE
STATUS
A/M
R
FESUFOTA1
B1/M
R
FERFUMTA1
B1/M
R
FERSULSY1
B1/M
R
FERSULTA1
B1/M
D
R
R
FOLACITA1
HYDROXIN1
C
D
R
R
IRODEXIN1
IROSUCIN1
C
R
ACETYLDT1
C
R
HEPARIIN4
D
D
D
B2
M
B2
D
D
D
D
D
R
R
R
NR
R
R
R
R
R
R
R
HEPARIIN1
HEPARIIN2
HEPARIIN3
PHYTOMTA1
PHYTOMIN1
PHYTOMIN2
PROSULIN1
STREPKIN1
STREPKIN2
STREPKIN3
TIROFIIN2
D
D
D
D
D
D
D
R
R
R
R
R
R
R
TIROFIIN1
TRAACICA1
TRAACIIN1
TRAACITA1
WARFARTA3
WARFARTA1
WARFARTA2
CODE
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
12. BLOOD PRODUCTS AND BLOOD SUBSTITUTES
Cryoprecipitate
Fresh Frozen Plasma
Gelatin Infusion (Succinylated Gelatin)
Packed Red Cells
Platelet Concentrate
13. CARDIOVASCULAR DRUGS
13.1 ANTI-ANGINAL DRUGS
Glyceryl Trinitrate Sublingual Tablet,
500 microgram
Isosorbide Dinitrate Sublingual
Tablet, 5 mg
Isosorbide Dinitrate Tablet, 10 mg
Nifedipine Tablet, 10 mg (Slow-Release)
Nifedipine Tablet, 20 mg (Slow -Release)
Nifedipine Tablet, 30 mg (GITS)
Propranolol Tablet, 10 mg
Propranolol Tablet, 40 mg
Propranolol Tablet, 80 mg
13.2 ANTIDYSRHYTHMIC DRUGS
Lidocaine Injection, 20 mg/ml
Propranolol Tablet, 10 mg
Propranolol Tablet, 40 mg
Propranolol Tablet, 80 mg
13.3 ANTIHYPERTENSIVE DRUGS
Amlodipine Tablet, 5 mg
Amlodipine Tablet, 10 mg
Atenolol + Hydrochlorthiazide Tablet,
(100 mg + 25 mg)
Atenolol + Hydrochlorthiazide Tablet,
(50 mg + 25 mg)
Atenolol Injection, 500 microgram/ml
Atenolol Tablet, 100 mg
Atenolol Tablet, 25 mg
Atenolol Tablet, 50 mg
Bendroflumethiazide Tablet, 2.5 mg
Bendroflumethiazide Tablet, 5 mg
LEVEL OF
NHIA
CARE
STATUS
CODE
B2
B2
B2
B2
B2
NR
NR
R
NR
NR
CRYOPRIN1
FRFRPLIN1
GELATIIN1
PARECEIN1
PLACONIN1
C
R
GLTRSUTA1
C
R
ISDISUTA1
C
B2
B2
B2
B2
B2
R
R
R
R
R
R
ISODINTA1
NIFEDITA1
NIFEDITA2
NIFEDITA3
PROPRATA1
PROPRATA2
B2
R
PROPRATA3
B2
B2
B2
B2
R
R
R
R
LIDOCAIN3
PROPRATA1
PROPRATA2
PROPRATA3
B2
B2
R
R
AMLODITA1
AMLODITA2
B2
R
ATEHYDTA2
B2
R
ATEHYDTA1
D
C
B2
B2
B2
B2
R
R
R
R
R
R
ATENOLIN1
ATENOLTA3
ATENOLTA1
ATENOLTA2
BENDROTA1
BENDROTA2
Ghana Essential Medicines List
THERAPEUTIC NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
Bisoprolol Tablet, 5 mg
Bisoprolol Tablet, 10 mg
Candesartan Tablet, 8 mg
Candesartan Tablet, 16 mg
Dobutamine Injection, 12.5 mg/ml
Hydralazine Injection, 20 mg
Hydralazine Tablet, 25 mg
Labetalol Injection, 5 mg/ml
Losartan Tablet, 25 mg
Losartan Tablet, 50 mg
Losartan Tablet, 100 mg
Methyldopa Tablet, 250 mg
Nifedipine Capsule, 5 mg
Nifedipine Capsule, 10 mg
Nifedipine Tablet, 10 mg (Slow-Release)
Nifedipine Tablet, 20 mg (Slow-Release)
Nifedipine Tablet, 30 mg (GITS)
Prazosin Tablet, 500 microgram
Propranolol Injection, 1 mg/ml
Propranolol Tablet, 10 mg
Propranolol Tablet, 40 mg
Propranolol Tablet, 80 mg
Ramipril Tablet, 2.5 mg
13.4
CARDIAC GLYCOSIDES
Digoxin Elixir, 50 microgram/ml
Digoxin Tablet, 125 microgram
Digoxin Tablet, 250 microgram
13.5 LIPID-REGULATING DRUGS
Atorvastatin Tablet, 10 mg
Atorvastatin Tablet, 20 mg
Fluvastatin Capsule, 20 mg
Rosuvastatin Tablet, 5 mg
Rosuvastatin Tablet, 10 mg
Simvastatin Tablet, 10 mg
Simvastatin Tablet, 20 mg
Simvastatin Tablet, 40 mg
Simvastatin Tablet, 80 mg
LEVEL OF
NHIA
CARE
STATUS
CODE
D
D
D
D
D
C
C
D
D
D
D
B2
D
D
B2
B2
B2
D
D
B2
B2
B2
C
NR
NR
NR
NR
NR
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
BISOPRTA1
BISOPRTA2
CANDESTA1
CANDESTA2
DOBUTAIN1
HYDRALIN1
HYDRALTA1
LABETAIN1
LOSARTTA1
LOSARTTA2
LOSARTTA3
METHYLTA1
NIFEDICA1
NIFEDICA2
NIFEDITA1
NIFEDITA2
NIFEDITA3
PRAZOSTA1
PROPRAIN1
PROPRATA1
PROPRATA2
PROPRATA3
RAMIPRTA1
C
C
C
R
R
R
DIGOXIEL1
DIGOXITA1
DIGOXITA2
C
C
D
D
D
C
C
D
D
R
R
R
R
R
R
R
R
R
ATORVATA1
ATORVATA2
FLUVASCA1
ROSUVATA1
ROSUVATA2
SIMVASTA1
SIMVASTA2
SIMVASTA3
SIMVASTA4
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
13.6
DRUGS USED IN SHOCK
Hydrocortisone Sodium Succinate
Injection, 100 mg
14. DERMATOLOGICAL PREPARATIONS
14.1 ANTIFUNGAL DRUGS
Benzoic Acid + Salicylic Acid Ointment,
(6 % + 3 %)
Ciclopirox Olamine Cream, 1 %
Clotrimazole + Hydrocortisone Cream,
(2 % + 1 % )
Clotrimazole Cream, 2 %
Clotrimazole Pessary, 100 mg
Clotrimazole Topical Solution, 1 %
Clotrimazole Vaginal Tablet, 200 mg
Gentian Violet Paint, 1 %
Miconazole Cream, 2 %
Miconazole Oral Gel, 24 mg/ml
Selenium Sulphide Shampoo, 2.5 %
14.2 ANTI-INFECTIVE DRUGS
Acyclovir Cream, 5 %
Cetrimide + Chlorhexidine Gluconate
Solution, (0.15 % + 0.015 %)
Cetrimide + Chlorhexidine Gluconate
Solution, (15 % + 1.5 %)
Cetrimide Cream, 0.5 %
14.3
LEVEL OF
NHIA
CARE
STATUS
B1/M
R
HYSOSUIN1
B1
R
BEACSAOI1
B1/M
R
CICOLACR1
C
NR
CLOHYDCR2
B2
R
CLOTRICR2
B2/M
B2
R
R
CLOTRIVP1
CLOTRISO1
B2/M
A/M
B2
B2
C
R
R
R
R
R
CLOTRIVP2
GENVIPSO1
MICONACR1
MICONAOG1
SELSULSH1
C
R
ACICLOCR1
B1
R
CETCHLSO1
B1
R
CETCHLSO2
B1/M
B1/M
Cetrimide Solution
Chlorhexidine Cream, 1 %
B1/M
Chlorhexidine Solution, 2.5 %
B1/M
Crotamiton Lotion, 10 %
B1
Silver Sulphadiazine Cream, 1 %
C
ANTI-INFLAMMATORY AND ANTIPRURITIC DRUGS
Betamethasone Valerate Cream, 0.05 %
Betamethasone Valerate Cream, 0.1 %
Calamine Cream, 15 %
Calamine Lotion, 15 %
Hydrocortisone Cream, 1 %
CODE
D
D
B1/M
B1/M
B1
R
CETRIMCR1
NR
R
R
R
R
CETRIMSO1
CHLORHCR1
CHLORHSO2
CROTAMLO1
SILSULCR1
R
R
R
R
R
BETVALCR1
BETVALCR2
CALAMICR1
CALAMILO1
HYDROCCR1
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
14.4 ASTRINGENT AGENTS
Salicylic Acid Ointment, 2 %
14.5 SCABICIDES AND PEDICULOCIDES
Benzyl Benzoate Lotion, 25 %
Lindane Lotion, 1 %
14.6 EMOLLIENTS AND VEHICLES
Aqueous Cream BP
14.7
15
OTHERS
Benzoyl Peroxide Solution, 5 %
16.
STATUS
CODE
B1
R
SALACIOI1
B2
B2
R
R
BENBENLO1
LINDANLO1
B1
R
AQUEOUCR1
C
R
BENPERSO1
C
C
R
R
BENPERSO2
CLINDASO1
Mercurochrome Solution
B2
R
MERCURSO1
C
NR
FLUORESO1
C
D
NR
NR
FLUOREST1
METHYLID1
D
D
C
NR
NR
NR
METHYLID2
ROSBENMI1
TROPICID1
B1
B2
NR
NR
DIASTRGL1
DIASTRMU1
Diagnostic Strips - Protein
Diagnostic Tablets - Glucose
B2
B1
NR
NR
DIASTRPR1
DIATABGL1
Diagnostic Tablets - Ketones
B1
NR
DIATABKE1
D
NR
EDROPHIN1
B1
B1/M
R
R
CHLORHCR1
CHLORHSO2
B2
NR
CHLORHSO1
B1
R
POVIDOSO1
DIAGNOSTIC AGENTS
Fluorescein Strips
Methylcellulose Eye Drops, 1 %
15.3
NHIA
CARE
Benzoyl Peroxide Solution, 10 %
Clindamycin Solution, 1 %
15.1 OPHTHALMIC DRUGS
Fluorescein Solution, 2 %
15.2
LEVEL OF
Methylcellulose Eye Drops, 1 %
Rose Bengal Minims, 1 %
Tropicamide Eye Drops, 1 %
BED-SIDE DIAGNOSTIC SUPPORT
Diagnostic Strips - Glucose
Diagnostic Strips - Multipurpose
OTHERS
Edrophonium Injection, 10 mg/ml
DISINFECTANTS
Chlorhexidine Cream, 1 %
Chlorhexidine Solution, 2.5 %
Chlorhexidine Solution, 4 %
in detergent base
Povidone Iodine (aq.) Solution, 10 %
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
LEVEL OF
NHIA
CARE
STATUS
CODE
17. DIURETICS
Bendroflumethiazide Tablet, 2.5 mg
Bendroflumethiazide Tablet, 5 mg
Furosemide Injection, 10 mg/ml
Furosemide Tablet, 40 mg
Mannitol Injection, 10 %
Mannitol Injection, 20 %
Metolazone Tablet, 5 mg
Spironolactone Tablet, 25 mg
Spironolactone Tablet, 50 mg
B2
B2
B2
B2
C
C
D
C
C
R
R
R
R
R
R
R
R
R
BENDROTA1
BENDROTA2
FUROSEIN1
FUROSETA1
MANNITIN1
MANNITIN2
METOLATA1
SPIRONTA1
SPIRONTA2
18. GASTROINTESTINAL DRUGS
18.1 ANTACIDS AND OTHER ANTIULCER DRUGS
Calcium Carbonate Tablet, 500 mg
Esomeprazole Capsule, 20 mg
Esomeprazole Capsule, 40 mg
Esomeprazole Injection, 40 mg
Magnesium Trisilicate Mixture
Magnesium Trisilicate Tablet, 500 mg
Omeprazole Capsule, 20 mg
Rabeprazole Capsule, 10 mg
Rabeprazole Capsule, 20 mg
Ranitidine Injection, 25 mg/ml
B1
D
D
D
A/M
A/M
D
D
D
C
R
R
R
NR
R
R
R
NR
R
NR
CALCARTA1
ESOMEPCA1
ESOMEPCA2
ESOMEPIN1
MAGTRIMI1
MAGTRITA1
OMEPRATA1
RABEPRCA1
RABEPRCA2
RANITIIN1
C
R
RANITITA1
D
D
D
D
D
C
C
R
R
R
R
R
R
R
DEXAMETA2
DEXAMETA1
DOMPERTA1
GRANISIN1
GRANISTA1
METOCLIN1
METOLATA1
R
PROHYDEL1
R
PROHYDIN1
R
PROTHETA1
18.2
Ranitidine Tablet, 150 mg
ANTI-EMETICS
Dexamethasone Tablet, 1 mg
Dexamethasone Tablet, 500 microgram
Domperidone Tablet, 10 mg
Granisetron Injection, 1 mg/ml
Granisetron Tablet, 1 mg
Metoclopramide Injection, 5 mg/ml
Metoclopramide Tablet, 10 mg
Promethazine Hydrochloride Elixir,
B1/M
5 mg/ 5 ml
Promethazine Hydrochloride Injection,
B1/M
25 mg/ml
B1/M
Promethazine Teoclate Tablet, 25 mg
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
LEVEL OF
NHIA
CARE
STATUS
18.3 ANTISPASMODIC DRUGS
Hyoscine -N-Butyl -Bromide Injection,
B1/M
20 mg/ml
Hyoscine -N-Butyl -Bromide Tablet, 10 mg B1/M
Mebeverine Tablet, 135 mg
C
18.4 CATHARTIC DRUGS
Bisacodyl Suppository, 10 mg
B2
CODE
R
HYOBUTIN1
R
R
HYOBUTTA1
MEBEVETA1
NR
BISACORE1
B2
C
R
R
BISACOTA1
LACTULLI1
Magnesium Sulphate, Salt
Paraffin Liquid
C
A/M
R
R
MAGSULPO1
PARAFFLI1
Senna Syrup, 7.5 mg/ 5 ml
B1
NR
SENNA SY1
B1
NR
SENNA TA1
M
R
SOOANARE1
M
R
SOOANAOI1
B2
R
SOANSTRE1
B2
R
SOANSTOI1
Oral Rehydration Salts Sachet
A/M
R
ORRESAPO1
Oral Rehydration Salts + Zinc Sachet
A/M
R
ORRESAPO2
B2
R
CODEINTA1
Bisacodyl Tablet, 5 mg
Lactulose Liquid, 3.1 - 3.7g/ 5 ml
Senna Tablet, 7.5 mg
18.5 ANTIHAEMORRHOIDAL DRUGS
Soothing Agent + Local Anaesthetic
Suppository
Soothing Agent + Local Anaesthetic
Ointment
Soothing Agent + Local Anaesthetic +
Steroid Suppository
Soothing Agent + Local Anaesthetic +
Steroid Ointment
18.6 DRUGS USED IN DIARRHOEA
18.6.1 Oral Replacement Solution
18.6.2 Antidiarrhoeal (Symptomatic) Drugs
Codeine Tablet, 30 mg
19. HORMONES, OTHER ENDOCRINE DRUGS AND CONTRACEPTIVES
19.1 ADRENAL HORMONES AND SYNTHETIC SUBSTITUTES
C
Dexamethasone Injection, 4 mg/ml
Hydrocortisone Sodium Succinate
B1/M
Injection, 100 mg
Prednisolone Tablet, 5 mg
B2
R
DEXAMEIN1
R
HYSOSUIN1
R
PREDNITA1
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
19.2
19.3
19.4
LEVEL OF
NHIA
CARE
STATUS
CONTRACEPTIVES
Condoms (Female)
A/PD
Condoms (Male)
A/PD
Ethinylestradiol + Levonorgestrel
PD
(Injectable Contraceptives)
Ethinylestradiol + Levonorgestrel
PD
(Oral Hormonal Contraceptives)
Ethinylestradiol + Norethisterone
PD
(Oral Contraceptives)
Levonorgestrel 0.75 mg
PD
(Oral contraceptive, mini pill)
Levonorgestrel Emergency
PD
Contraceptives, 1.5 mg
Levonorgestrel Implant Contraceptives
PD
Levonorgestrel Intra Uterine
PD
Contraceptives (Hormonal)
Medroxyprogesterone Acetate Injection,
PD
150 mg (Depot)
ESTROGENS
Conjugated Oestrogen + Norgesterol
C
Tablet, 625 microgram + 150 microgram
Conju gated Oestrogen Tablet,
D
625 microgram
Conjugated Oestrogen Vaginal cream,
D
625 micrograms/g
INSULINS AND OTHER ANTIDIABETIC DRUGS
Glibenclamide Tablet, 5 mg
B2
Gliclazide Tablet, 80 mg
C
Glimepiride Tablet, 1 mg
C
Glimepiride Tablet, 2 mg
C
Glimepiride Tablet, 4 mg
C
Glucagon Injection, 1 mg
C
Insulin aspart, 100 units/ml
D
Insulin detemir, 100 units/ml
D
Insulin glargine, 100 units/ml
D
Insulin lispro, 100 units/ml
D
Insulin pre -mixed (30/70) HM Injection,
C
100 units/ml
Insulin Soluble HM, 100 units/ml
C
CODE
NR
NR
CONDOMFE
CONDOMMA
NR
ETHLEVIN1
NR
ETHLEVTA1
NR
ETHNORTA1
NR
LEVONOTA1
NR
LEVONOTA2
NR
LEVONOTA3
NR
LEINUTIN1
NR
MEDACEIN1
R
COOENOTA1
R
CONOESTA1
R
CONOESVC1
R
R
R
R
R
R
NR
NR
NR
NR
GLIBENTA1
GLICLATA1
GLIMEPTA1
GLIMEPTA2
GLIMEPTA4
GLUCAGIN1
INSASPIN1
INSDETIN1
INSGLAIN1
INSLISIN1
R
INPRMIIN1
R
INSSOLIN1
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
Isophane Insulin Injection (HM),
100 units/ml
Metformin Tablet, 500 mg
Pioglitazone Tablet, 15 mg
Pioglitazone Tablet, 30 mg
Rosiglitazone Tablet, 4 mg
20.2
CODE
ISOINSIN1
B2
C
C
C
R
R
R
R
METFORTA1
PIOGLITA1
PIOGLITA2
ROSIGLTA1
B2
R
TOLBUTTA1
D
NR
CLOMIFTA1
D
R
MEDACETA1
D
R
NORETHTA1
THYROID HORMONES AND ANTITHYROID DRUGS
Carbimazole Tablet, 20 mg
C
Carbimazole Tablet, 5 mg
C
R
R
CARBIMTA2
CARBIMTA1
Norethisterone Tablet, 5 mg
20.
20.1
STATUS
R
19.6 PROGESTOGENS
Medroxyprogesterone Acetate Tablet,
5 mg
19.8
NHIA
CARE
C
Tolbutamide Tablet, 500 mg
19.5 OVULATION INDUCERS
Clomifene Citrate Tablet, 50 mg
19.7
LEVEL OF
Levothyroxine Tablet, 100 microgram
Levothyroxine Tablet, 50 microgram
C
C
R
R
LEVSODTA3
LEVSODTA2
Propylthiouracil Tablet, 50 mg
D
R
PROPYLTA1
D
R
BROMOCTA1
B2
NR
TUBERCIN1
C
R
ANIMGLIN1
B1
NR
ANRAIMIN1
B1
NR
ANSNVEIN1
B1/M
NR
TETTOXIN1
B1/M
R
TETIMMIN1
C
R
TETIMMIN2
OTHER END OCRINOLOGICAL DRUGS
Bromocriptine Tablet, 2.5 mg
IMMUNOLOGICALS
DIAGNOSTIC AGENTS
Tuberculin (PPD) Injection, 20 units/ml
SERA AND IMMUNOGLOBULINS
Anti D Rh Immunoglobulin Injection
Antirabies Immunoglobulins Injection,
1000 IU/ 5 ml
Anti -Snake Serum (West African
Polyvalent) Injection, 1500 IU/ml
Tetanus Toxoid Injection, 40 IU (0.5 ml)
Tetanus Immunoglobulins Injection,
250 IU/ml
Tetanus Immunoglobulins Injection,
5000 IU/amp
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
LEVEL OF
NHIA
CARE
STATUS
20.3 VACCINES
20.3.1 For Universal Immunization
Five in One Vaccine Injection
PD
(Diphtheria, Pertussis, Tetanus,
Haemophilus influenzae b and Hepatitis B)
Bacillus Calmette-Guérin (BCG)
PD
Vaccine Injection
CODE
NR
FIINONIN1
NR
BCGVACIN1
PD
PD
PD
NR
NR
NR
HEPBVAIN1
MEAVACIN1
POLVACSO1
B1/PD
PD
NR
NR
TETVACIN1
YEFEVAIN1
B1
B1
NR
NR
MENVACIN1
RABVACIN1
Tetanus Toxoid Injection, 40 IU (0.5 ml)
B1
Tetanus Vaccine Injection, 40 IU/ 5 ml B1/PD
Yellow Fever Vaccine Injection
PD
21. MUSCLE RELAXANTS AND CHOLINEATERASE INHIBITORS
Atracurium Injection, 10 mg/ml
D
Neostigmine Injection, 0.5 mg
C
NR
NR
NR
TETTOXIN1
TETVACIN1
YEFEVAIN1
NR
NR
ATRACUIN1
NEOSTIIN2
Neostigmine Injection, 2.5 mg
Rocuro nium Injection, 10 mg/ml
C
D
R
NR
NEOSTIIN1
ROCUROIN1
Suxamethonium Injection, 100 mg/ 2 ml
Vecuronium Bromide Injection, 10 mg
C
C
NR
NR
SUXAMEIN1
VECBROIN1
C
B1/M
R
R
ACICLOEO1
CHLORAID1
B1/M
C
R
R
CHLORAEO1
CIPROFID1
Erythromycin Ointment, 0.5 %
Fluconazole Ophthalmic Solution
B1
SD
NR
NR
ERYTHROI1
FLUCONID1
Genta micin Eye Drops, 0.3 %
Gentamicin Ointment, 0.3 %
B1
B1
R
NR
GENTAMID1
Natamycin Eye Drops, 5 %
SD
NR
20.3.2
Hepatitis B Vaccine Injection
Measles Vaccine Injection
Poliomyelitis Vaccine Oral Solution
Tetanus Vaccine Injection, 40 IU/ 5 ml
Yellow Fever Vaccine Injection
For Specific Groups of Individuals
Meningococcal Vaccine Injection
Rabies Vaccine Injection
22. OPHTHALMOLOGICAL PREPARATIONS
22.1 ANTI-INFECTIVE AGENTS
Acyclovir Eye Ointment, 3%
Chloramphenicol Ear, Eye Drops, 0.5 %
Chloramphenicol Eye Ointment, 1 %
Ciprofloxacin Eye Drops, 3 %
GENTAOI1
NATAMYID1
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
LEVEL OF
NHIA
CARE
STATUS
B1
B1
R
R
TETRACEO1
TETRACEO2
C
C
R
NR
LODOXAID1
SODCROID1
C
C
SD
SD
SD
SD
SD
NR
R
NR
R
NR
NR
NR
ATROPIID1
ATROPIID2
CYCLOPID1
CYCLOPID2
CYCLOPID3
PHENYLID2
PHENYLID1
C
C
C
C
C
C
R
R
R
R
R
R
CORANTID1
CORANTEO1
DEXAMEID1
DEXAMEEO1
HYDROCCR1
HYDROCEO1
C
R
ACETAZIN1
C
R
ACETAZTA1
SD
NR
BIMATOID1
SD
NR
LATANOID1
C
C
C
R
R
R
PILOCAID1
PILOCAID2
TIMMALID1
B1/M
B1/M
A/M
A/M
SD
R
R
R
R
NR
ERGOMEIN1
ERGOMEIN2
ERGOTATA1
ERGOMETA1
MIFEPRTA1
Tetracycline Eye Ointment, 0.5 %
Tetracycline Eye Ointment, 1 %
ANTI-ALLERGIC
Lodoxamide Eye Drops, 0.1 %
Sodium Cromoglycate Eye Drops, 4 %
22.3 MYDRIATICS AND CYCLOPLEGICS
Atropine Sulphate Eye Drops, 0.5 %
Atropine Sulphate Eye Drops, 1 %
Cyclopentolate Eye Drops, 0.5 %
Cyclopentolate Eye Drops, 1 %
Cyclopentolate Eye Drops, 2 %
Phenylephrine Eye Drops, 10 %
Phenylephrine Eye Drops, 2.5 %
22.4 ANTI-INFLAMMATORY AGENTS
Corticosteroid + Antibiotic Eye Drops
Corticosteroid + Antibiotic Eye Ointment
Dexamethasone Eye Drops, 1 %
Dexamethasone Eye Ointment, 1 %
Hydrocortisone Eye Drops, 1 %
Hydrocortisone Eye Ointment, 1 %
22.5 MIOTICS AND DRUGS USED IN GLAUCOMA
Acetazolamide Injection, 500 mg
Acetazolamide Tablet, 250 mg
Bimatoprost Eye Drops,
300 micrograms/ml
Latanoprost Eye Drops,
50 micrograms/ml
Pilocarpine Eye Drops, 2 %
Pilocarpine Eye Drops, 4 %
Timolol Maleate Eye Drops, 0.5 %
CODE
22.2
23. OXYTOCICS AND ANTI-OXYTOCICS
23.1 OXYTOCICS
Ergometrine Injection, 0.2 mg/ml
Ergometrine Injection, 0.5 mg/ml
Ergometrine Tablet, 0.2 mg
Ergometrine Tablet, 0.5 mg
Mifepristone Tablet, 600 microgram
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
LEVEL OF
NHIA
CLASS
FORM AND STRENGTH
CARE
STATUS
Misoprostol Tablet, 100 microgram
Misoprostol Tablet, 200 microgram
Misoprostol Tablet, 25 microgram
Misoprostol Tablet, 50 microgram
Misoprostol Vaginal Tablet,
200 microgram
Oxytocin Injection, 5 units/ml
Oxytocin Injection, 10 units/ml
23.2 ANTI-OXYTOCICS
Salbutamol Sulphate Injection,
500 microgram/ml
Salbutamol Tablet, 4 mg
24. PSYCHOTHERAPEUTIC DRUGS
Amitriptyline Tablet, 10 mg
Amitriptyline Tablet, 25 mg
Amitr iptyline Tablet, 50 mg
Chlordiazepoxide Hydrochloride Tablet,
5 mg
Chlorpromazine Injection, 25 mg/ml
Chlorpromazine Tablet, 25 mg
Chlorpromazine Tablet, 50 mg
Chlorpromazine Tablet, 100 mg
Diazepam Injection, 5 mg/ml
Diazepam Tablet, 5 mg
Diazepam Tablet, 10 mg
Fluox etine Capsule, 20 mg
Fluphenazine Deconoate Injection,
25 mg/ml
Haloperidol Injection, 5 mg
Haloperidol Tablet, 5 mg
Haloperidol Tablet, 10 mg
Imipramine Tablet, 25 mg
Lithium Carbonate Tablet,
200 mg (Slow-Release)
Lithium Carbonate Tablet,
500 mg (Slow-Release)
Lorazepam Tablet, 2 mg
Methylphenidate Hydrochloride Tablet,
5 mg
PD
PD
A/PD
A/PD
NR
NR
NR
NR
MISOPRTA1
MISOPRTA2
MISOPRTA3
MISOPRTA4
PD
R
MISOPRVP1
B1/M
B1/M
R
R
OXYTOCIN1
OXYTOCIN2
B2
R
SALSULIN1
B1
R
SALBUTTA2
C
C
C
R
R
R
AMITRITA1
AMITRITA2
AMITRITA3
C
R
CHLORDTA1
B2
B2
B2
B2
B1/M
M
M
C
R
R
R
R
R
R
R
R
CHLPROIN1
CHLPROTA1
CHLPROTA2
CHLPROTA3
DIAZEPIN1
DIAZEPTA1
DIAZEPTA
FLUOXECA1
SD
R
FLUDECIN1
SD
C
C
C
R
R
R
R
HALOPEIN1
HALOPETA1
HALOPETA2
IMIPRATA1
SD
R
LITCARTA1
SD
R
LITCARTA2
B2
R
LORAZETA2
SD
R
METHYDTA1
CODE
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
Olanzapine Injection, 5 mg/ml
Olanzapine Tablet, 5 mg
Olanzapine Tablet, 10 mg
Risperidone Liquid, 1 mg/ml
Risperidone Tablet, 1 mg
Risperidone Tablet, 2 mg
Risperidone Tablet, 500 microgram
Sertraline Tablet, 50 mg
Sertraline Tablet, 100 mg
Sodium Valproate Tablet, 200 mg
LEVEL OF
NHIA
CARE
STATUS
SD
SD
SD
SD
SD
SD
SD
SD
SD
D
R
R
R
R
R
R
R
R
R
R
OLANZAIN1
OLANZATA1
OLANZATA2
RISPERLI1
RISPERTA1
RISPERTA2
RISPERTA1
SERTRATA1
SERTRATA2
SODVALTA1
R
ADRENAIN1
R
AMINOPIN1
R
BECDIPGA2
R
BUDFORGA1
R
BUDFORGA2
R
R
BUDESOGA1
BUDESOGA2
R
FLUSALGA1
R
R
R
FLUTICGA1
FLUTICGA2
FLUTICGA3
R
HYSOSUIN1
R
PREDNITA1
R
SALBUTGA1
R
R
R
R
R
SALBUTGA2
SALBUTGA3
SALBUTSY1
SALBUTTA1
SALBUTTA2
25. DRUGS ACTING ON THE RESPIRATORY TRACT
25.1 ANTI-ASTHMATIC DRUGS
Adrenaline (Epinephrine) Injection,
B1/M
1 mg/ ml (1:1000)
Aminophylline Injection, 250 mg/10 ml
B2
Beclometasone dipropionate Inhaler,
100 microgram /metered dose (200 doses) B2
Budesonide + Formoterol
SD
(80 microgram/ 4.5 microgram)
Budesonide + Formoterol
SD
(160 microgram/ 4.5 microgram)
Budesonide 100 microgram
SD
Budesonide 200 microgram
SD
Fluticasone + Salmeterol
SD
(250 micrograms/ 50 microgram)
Fluticasone 50 microgram
SD
Fluticasone 125 microgram
SD
Fluticasone 250 microgram
SD
Hydrocortisone Sodium Succinate
B1/M
Injection, 100 mg
Prednisolone Tablet, 5 mg
B2
Salbutamol Inhaler,
100 microgram/metered dose Inhaler
B1
(200 doses )
Salbutamol Nebulizer, 2.5 mg Nebules
B1
Salbutamol Nebulizer, 5 mg Nebules
B1
Salbutamol Syrup, 2 mg/ 5 ml
B1
Salbutamol Tablet, 2 mg
B1
Salbutamol Tablet, 4 mg
B1
CODE
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
LEVEL OF
NHIA
CARE
STATUS
CODE
Theophylline Tablet, 200 mg
C
R
THEOPHTA1
(Slow-Release)
25.2 ANTITUSSIVES
Carbocisteine Capsule, 375 mg
B1
R
CARBOCCA1
Carbocisteine Syrup Paediatric,
R
CARBOCSY1
B1
125 mg/ 5ml
Carbocisteine Syrup, 250 mg/ 5ml
B1
R
CARBOCSY2
Simple Linctus (Paediatric) BPC
A/M
R
SIMLINSY1
A/M
Simple Linctus BPC
R
SIMLINSY2
26. SOLUTIONS CORRECTING WATER AND ELECTROLYTE ABNORMALITIES
26.1 ORAL PREPARATIONS
A/M
Oral Rehydration Salts, Sachet
R
ORRESAPO1
Potassium Chloride Tablet, 600 mg
R
POTCHLTA1
B2
(Enteric-Coated)
26.2 PARENTERAL SOLUTIONS
Badoe's Solution Injection, 1000 ml
Cholera Replacement Fluid Injection,
(5:4:1)
Darrow's Solution Injection,
Half-Strength (250 ml)
Dextrose in Sodium Chloride Intravenous
Infusion, 4.3% in 0.18% (250 ml)
Dextrose in Sodium Chloride Intravenous
Infusion, 5 % in 0.9% (500 ml )
Dextrose in Sodium Chloride Intravenous
Infusion, 10 % in 0.18 % (250 ml )
Dextrose Infusion, 10 % (250 ml)
Dextrose Infusion, 10 % (500 ml )
Dextrose Infusion, 20 % (250 ml )
Dextrose Infusion, 5 % (250 ml )
Dextrose Infusion, 5 % ( 500 ml )
Dextrose Infusion, 50 % ( 50 ml )
Potassium Chloride Injection,
20 mEq/10 ml
Ringers Lactate Intravenous Infusion,
500 ml
B2
R
BADOESIN1
B1
R
CHREFLIN1
B2
R
DARROWIN1
B1
R
DESOCHIN1
B1/M
R
DESOCHIN2
C
R
DESOCHIN3
B2
B2
C
B1/M
B1/M
B2
R
R
R
R
R
R
DEXTROIN3
DEXTROIN4
DEXTROIN5
DEXTROIN1
DEXTROIN2
DEXTROIN6
C
R
POTCHLIN1
B1/M
R
RINLACSO1
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
26.3
27.
28.
28.1
28.2
28.3
LEVEL OF
NHIA
CARE
STATUS
Sodium Bicarbonate Injection, 8.4 %
C
Sodium Chloride + Potasium Chloride
SD
Injection, 0.9 % + 20 mMol (500 ml)
Sodium Chloride Injection, 0.45 %
B2
(250 ml)
Sodium Chloride Injection, 0.9% (250 ml) B1
Sodium Chloride Injection, 0.9% (500 ml) B1
MISCELLANEOUS
Water for Injection
A/M
VITAMINS AND MINERALS
Calciferol Tablet, 10 000 units
D
Calcium Gluconate Injection,
C
100 mg/ml
Calcium + Vitamin D Tablet,
C
(97 mg + 10 microgram)
A/M
Multivitamin Syrup
A/M
Multivitamin Tablet
Pyridoxine Tablet, 100 mg
B2
Pyridoxine Tablet, 50 mg
B2
A/M
Retinol Soft Capsule, 100 000 IU
Retinol Soft Capsule, 200 000 IU
A/M
Thiamine Injection, 100 mg
C
Thiamine Tablet, 25 mg
C
Thiamine Tablet, 50 mg
C
Thiamine Tablet, 100 mg
C
OTHER SPECIALIST DRUGS
DRUGS FOR EAR, NOSE AND THROAT
A/M
Sodium Chloride Nasal Drops, 0.9 %
DRUGS FOR DENTISTRY
Chlorhexidine Mouthwash, 0.2 %
B2
Lidocaine + Adrenaline Cartridge,
B2
(20 mg/ml + [1:80 000/1:100 000])
Miconazole Oral Gel, 24 mg/ml
B2
Nystatin Ointment, 100 000 IU
B2
DRUGS FOR HIV/AIDS
Abacavir Oral Solution, 20 mg/ml
PD
Abacavir Tablet, 300 mg
PD
R
CODE
SODBICIN1
NR SOCHPOIN1
R
SODCHLIN1
NR SODCHLIN2
R SODCHLIN3
R
WATFORIN1
R
CALCIFTA1
R
CALGLUIN1
R
CALVITTA1
R
R
R
R
R
R
R
R
R
R
MULTIVSY1
MULTIVTA1
PYRIDOTA3
PYRIDOTA2
RETSOFCA1
RETSOFCA2
THIAMIIN1
THIAMITA1
THIAMITA2
THIAMITA3
R
SODCHLND1
R CHLORHMW1
R
LIDADRIN1
R
R
MICONAOG1
NYSTATOI1
NR
NR
ABACAVSO1
ABACAVTA1
Ghana Essential Medicines List
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
LEVEL OF
NHIA
CARE
STATUS
CODE
Didanosine Capsule, 200 mg
Didanosine Oral solution, 10 mg/ml
PD
PD
NR
NR
DIDANOCA1
DIDANOSO1
Didanosine Tablet, 100 mg
Didanosine Tablet, 150 mg
PD
PD
PD
PD
PD
PD
PD
PD
PD
NR
NR
NR
NR
NR
NR
NR
NR
NR
DIDANOTA3
DIDANOTA4
DIDANOTA1
DIDANOTA2
EFAVIRCA2
EFAVIRCA3
EFAVIRCA1
EFAVIRSY1
EFAVIRTA1
Emtricitabine Tablets, 200 mg
Indinavir Tablet, 400 mg
Lamivudine Oral solution, 10 mg/ml
Lamivudine Tablet, 150 mg
Liponavir + Ritonavir Capsule,
(133.3 mg + 33.3 mg)
Liponavir + Ritonavir Oral solution,
(80 mg + 20 mg/ml)
Nelfinavir Tablet, 250 mg
Nevirapine Suspension, 10 mg/ml
Nevirapine Tablet, 200 mg
Ritonavir Capsule, 100 mg
PD
PD
PD
PD
NR
NR
NR
NR
EMTRICTA1
INDINATA1
LAMIVUSO1
LAMIVUTA1
PD
NR
LIPRITCA1
PD
NR
LIPRITSO1
PD
PD
PD
PD
NR
NR
NR
NR
NELFINTA1
NEVIRASU1
NEVIRATA1
RITONACA1
Saquinavir Capsule, 200 mg
Stavudine Capsule, 15 mg
Stavudine Capsule, 20 mg
PD
PD
PD
NR
NR
NR
SAQUINCA1
STAVUDCA1
STAVUDCA2
Stavudine Capsule, 30 mg
Stavudine Capsule, 40 mg
Stavudine Oral Solution, 1 mg/ml
Tenofovir Tablet, 300 mg
Zidovudine + Lamivudine Tablet,
(300 mg + 150 mg)
Zidovudine Capsule, 100 mg
Zidovudine Syrup, 10 mg/ml
Zidovudine Tablet, 300 mg
PD
PD
PD
PD
NR
NR
NR
NR
STAVUDCA3
STAVUDCA4
STAVUDSO1
TENOFOTA1
PD
NR
ZIDLAMTA1
PD
PD
PD
NR
NR
NR
ZIDOVUCA1
ZIDOVUSY1
ZIDOVUTA1
Didanosine Tablet, 25 mg
Didanosine Tablet, 50 mg
Efavirenz Capsule, 100 mg
Efavirenz Capsule, 200 mg
Efavirenz Capsule, 50 mg
Efavirenz Syrup, 30 mg/ml
Efavirenz Tablet, 600 mg
Ghana Essential Medicines List
LEVEL OF
NHIA
CARE
STATUS
Finasteride Tablet, 5 mg
SD
R
FINASTTA1
Tamsulosin Capsule, 400 microgram
SD
R
TAMSULCA1
Terazosin Tablet, 2 mg
SD
R
TERAZOTA1
Terazosin Tablet, 5 mg
SD
R
TERAZOTA2
THERAPEUTIC
NAME OF DRUG, DOSAGE
CLASS
FORM AND STRENGTH
28.4
CODE
DRUGS FOR UROLOGY
OTHER PUBLICATIONS
•
Ghana Assessment of Medicines Procurement and Supply Management
Systems in the Public Health Sector, A Country Report (2009)
•
Partners Mapping for Medicines Procurement and Supply Management in
Ghana (2009)
•
Standard Treatment Guidelines (2004)
•
Ghana Essential Medicines List (2004)
•
National Drugs Policy (2004)
•
Code of Ethics and Standards of Practice for Traditional Medicines
Practitioners in Ghana (2003)
•
Standards of Pharmaceutical Care for Health Institutions in Ghana (2003)
•
Increasing Access to Medicines: An Assessment and Policy Options for
Ghana (2003)
•
An Assessment of the Pharmaceutical Sector in Ghana (2002)
•
Logistics Management of Public Sector Health Commodities in Ghana:
Standard Operating Procedures - Regional Medical Stores to Service
Delivery Points (2002)
•
Drugs and Therapeutics Committee (DTC) Training Manual (2002)
•
Standard Treatment Guidelines (2000)
•
Ghana Essential Drugs List (2000)
•
Baseline Survey on the Pharmaceutical Sector in Ghana (1999)
•
Procurement Procedure Manual (1999)
•
Procurement Training Manual
•
Rational Drug Use Training Manual